CA2+ PHARMA
Business purpose.
Structure de regroupement à l'achat
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- Headcount unknown
- Created
- 6 Feb 2019
- Share capital
- 18,000.00 EUR
- Registered with the trade register
- 19 Feb 2019
- Financial year end
- 31/10
- Establishments
- 1
Directors
- PHARMACIE CHENE-MARSAUDON Directeur general
- PHARMACIE DE LA PLACE Directeur general
- PHARMACIE D'ANSAC Directeur general
- CATHERINE BOULIN Directeur general
- PHARMACIE DE SAINT GENCE Directeur general
- PHARMACIE SAINT JACQUES Directeur general
- SELARL CORREPHARM Directeur general
- PHARMACIE BARBE Directeur general
- PHARMACIE COUBRET Directeur general
- PHARMACIE DUTREIX-GIROIR Directeur general
- GRANDE PHARMACIE DU TRECH Directeur general
- PHAMARCIE DUPUYTREN Directeur general
- LANDOUGE PHARMA Directeur general
- PHARMACIE SARLANDIE Directeur general
- PHARMACIE PHARMAPILOU Directeur general
- PHARMACIE DU VAL DE GORRE Directeur general
- SELAS LIMPHARM President de SAS
Other companies at the same address
5 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
89 / 100 A
Confidence: high · computed on the financial year ended 31 Oct 2025
- Equity to assets (87.2 %)
- 28.4 out of 30
- EBITDA margin (19.0 %)
- 19.0 out of 25
- Liquidity (782.9 %)
- 18.1 out of 20
- Debt (0.1 %)
- 15.0 out of 15
- Revenue trend (19.5 %)
- 8.7 out of 10
formula fin-1.0
Legal score
96 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (7.8 years)
- 15.6 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Oct 2025 | 211,479 € | +19.5 % | 40,122 € | 34,268 € |
| 31 Oct 2024 | 176,948 € | -10.0 % | 11,476 € | 9,477 € |
| 31 Oct 2023 | 196,694 € | +13.9 % | 22,141 € | 17,456 € |
| 31 Oct 2021 | 172,662 € | +76.8 % | 20,839 € | 17,005 € |
| 31 Oct 2020 | 97,686 € | +1,062.7 % | 44,935 € | 38,643 € |
| 31 Oct 2019 | 8,402 € | first year on record | -4,698 € | -4,699 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Legal notices
-
Filing of accounts 27 Mar 2026
- Court :
- Greffe du Tribunal des Activités Economiques de limoges
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/10/2025
BODACC C n 20260060, annonce n 4720 · Proof of publication (PDF)
-
Amendment 25 May 2025
- Court :
- Greffe du Tribunal des Activités Economiques de Limoges
- Amendment :
- modification survenue sur l'administration
BODACC B n 20250100, annonce n 2377 · Proof of publication (PDF)
-
Filing of accounts 16 May 2025
- Court :
- Greffe du Tribunal des Activités Economiques de limoges
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250094, annonce n 6256 · Proof of publication (PDF)
-
Amendment 10 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de Limoges
- Amendment :
- modification survenue sur l'administration
BODACC B n 20240132, annonce n 2206 · Proof of publication (PDF)
-
Filing of accounts 4 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de limoges
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/10/2023
BODACC C n 20240128, annonce n 14242 · Proof of publication (PDF)
-
Filing of accounts 11 Oct 2022
- Court :
- Greffe du Tribunal de Commerce de limoges
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/10/2021
BODACC C n 20220197, annonce n 7530 · Proof of publication (PDF)
-
Amendment 9 Oct 2022
- Court :
- Greffe du Tribunal de Commerce de Limoges
- Amendment :
- modification survenue sur l'administration
BODACC B n 20220196, annonce n 2629 · Proof of publication (PDF)
-
Amendment 7 Oct 2022
- Court :
- Greffe du Tribunal de Commerce de Limoges
- Amendment :
- modification survenue sur l'administration
BODACC B n 20220195, annonce n 2135 · Proof of publication (PDF)
-
Amendment 12 Jul 2022
- Court :
- Greffe du Tribunal de Commerce de Limoges
- Amendment :
- modification survenue sur l'administration
BODACC B n 20220134, annonce n 3278 · Proof of publication (PDF)
-
Filing of accounts 21 Apr 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE LIMOGES
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/10/2020
BODACC C n 20210078, annonce n 4060 · Proof of publication (PDF)
-
Filing of accounts 25 Mar 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE LIMOGES
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/10/2019
BODACC C n 20200060, annonce n 1047 · Proof of publication (PDF)
-
Incorporation 27 Feb 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE LIMOGES
BODACC A n 20190041, annonce n 1684 · Proof of publication (PDF)
Filings and annual accounts as PDF →
Filings and accounts
- Formality 15 May 2025
Change history
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Registered office: 8 avenue du 14 Juillet 87570 Rilhac-Rancon 2 Oct 2026
- Share capital: 18,000 € 2 Oct 2026
Frequently asked questions about CA2+ PHARMA
- What is the SIREN number of CA2+ PHARMA?
- The SIREN number of CA2+ PHARMA is 848418778. Its intra-community VAT number is FR14848418778.
- Where is the head office of CA2+ PHARMA?
- Head office address: 8 AVENUE DU 14 JUILLET, 87570 RILHAC-RANCON.
- When was CA2+ PHARMA founded?
- CA2+ PHARMA was founded on 6 Feb 2019.
- What does CA2+ PHARMA do?
- Its declared main activity is: Wholesale (intercompany trade) of pharmaceutical goods (NAF code 46.46Z).
- Who runs CA2+ PHARMA?
- The officers listed in the register are PHARMACIE CHENE-MARSAUDON (Directeur general), PHARMACIE DE LA PLACE (Directeur general), PHARMACIE D'ANSAC (Directeur general).
- What is the revenue of CA2+ PHARMA?
- The latest published revenue is 211,479 €, for the 2025 financial year.
- Is CA2+ PHARMA subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.